Avidity Biosciences
142 hedge funds and large institutions have $522M invested in Avidity Biosciences in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 62 increasing their positions, 40 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
6.11% less ownership
Funds ownership: 116.41% → 110.3% (-6.1%)
43% less capital invested
Capital invested by funds: $915M → $522M (-$393M)
Holders
142
Holding in Top 10
2
Calls
$601K
Puts
$14K
Top Buyers
| 1 | +$4.44M | |
| 2 | +$3.51M | |
| 3 | +$3.14M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.68M |
| 5 |
CC
Casdin Capital
New York
|
+$2.55M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$5.42M | |
| 3 | -$4.04M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.08M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.01M |